95233-37-7 (4-(4-氯苯基)环己基羧酸,4-(4-Chlorophenyl)cyclohexanecarboxylic acid)

CAS号:
95233-37-7
中文名称:
4-(4-氯苯基)环己基羧酸
英文名称:
4-(4-Chlorophenyl)cyclohexanecarboxylic acid
分子式:
C13H15ClO2
分子量:
238.710003137589

4-(4-氯苯基)环己基羧酸(95233-37-7)名称与标识符

名称

中文别名:
4-(4-氯苯基)环己基羧酸;4-(4-氯苯基)环己基羧酸3-羟基苯乙酮;4-(4-氯苯基)环己基-1-羧酸;阿托伐醌中间体(2);反式 4-(4-氯苯基)环己基羧酸;
英文别名:
4-(4-Chlorophenyl)cyclohexanecarboxylic acid;(E)-4-(4-CHLOROPHENYL)CYCLOHEXANECARBOXYLIC ACID;4-(4'-Chlorophenyl)cyclohexancarboxylic acid;trans-4-(4-Chlorophenyl)cyclohexanecarboxylic acid;1,4-Dioxaspiro[4.5]dec-7-ene,8-(4-chlorophenyl);4-(4-chlorophenyl)cycIohex-3-en;4-(4-chlorophenyl)cyclohex-3-enone monoehtylene ketal;4-(4-chlorophenyl)cyclohexane-1-carboxylic acid;4-(4-CHLOROPHENYL)CYCLOHEXYLCARBOXYLIC ACID;4,4-DIMETHYL-6-ETHYNYLTHIOCHROMAN;Cyclohexanecarboxylic acid, 4-(4-chlorophenyl)-, trans-;Cyclohexanecarboxylic acid, 4-(4-chlorophenyl)-;Atovaquone Related Compound 1;cis-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid;4-(4-CHLOROPHENYL)CYCLOHEXANE CARBO;4-(4-Chlorophenyl)cyclohexanecarboxylic acid (ACI);MFCD00665919;MFCD06797626;trans 4-(4-chlorophenyl)-cyclohexane-1-carboxylic acid;1346600-43-8;SCHEMBL12905598;SCHEMBL637532;4-(4-chlorophenyl) cyclohexanecarboxylic acid;95233-37-7;12N-240;SB66535;DB-057569;(E)-4-(4-Chloro-phenyl)cyclohexanecarboxylic acid;SCHEMBL918204;49708-81-8;DTXSID80964358;4-(4-Chlorophenyl)cyclohexanecarboxylic acid, trans-;4-(4-CHLOROPHENYL)CYCLOHEXANE CARBOXYLIC ACID;CS-W019411;DS-0937;NS00003962;Oprea1_374119;E70394;4-(4-chlorophenyl)cyclohexanecarboxylic acid, AldrichCPR;(1r,4r)-4-(4-chlorophenyl)cyclohexane-1-carboxylic acid;4-(4-Chlorophenyl)cyclohexanecarboxylic acid, cis-;Cyclohexanecarboxylic acid, 4-(4-chlorophenyl)-, trans-; trans-4-(4-Chlorophenyl)cyclohexanecarboxylic acid; trans-4-(p-Chlorophenyl)cyclohexanecarboxylic acid; trans-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid;trans-?4-?(4-?Chlorophenyl)?cyclohexanecarboxyli?c Acid;H7K9WUV7GP;DB-307755;trans-4-(4-chlorophenyl)cyclohexane carboxylic acid;PS-7612;trans-4-(p-chlorophenyl)cyclohexane carboxylic acid;CCG-41223;AKOS005080984;NS00077684;4-(4-chlorophenyl)-cyclohexane-1-carboxylic acid;NXXDIEYTMQYWJU-HOMQSWHASA-N;Cyclohexanecarboxylic acid, 4-(4-chlorophenyl)-, cis-;J-513486;cis-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid; Cyclohexanecarboxylic acid, 4-(4-chlorophenyl)-, cis-; cis-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid;trans-4-(4-Chlorophenyl)cyclohexane-1-carboxylic acid;925WLS25HD;4-(4-chlorophenyl)cyclohexane-l-carboxylic acid;SY116250;trans-4-(4-Chlorophenyl)cyclohexanecarboxylicacid;trans-4-(p-Chlorophenyl)cyclohexanecarboxylic acid;(1r,4r)-4-(4-Chlorophenyl)cyclohexanecarboxylic acid;trans 4-(4-chlorophenyl)cyclohexane-1-carboxylic acid;AC-6139;CS-W012833;SY109890;SB66837;4-(4-chloro-phenyl)-cyclohexanecarboxylic acid;4-(4-chlorophenyl)-cyclohexanecarboxylic acid;SR-01000631315-1;AKOS015999167;4-(4-Chlorophenyl)cyclohexan-1-carboxylic acid;

标识符

MDL:
MFCD00665919
InChIKey:
NXXDIEYTMQYWJU-UHFFFAOYSA-N
Inchi:
1S/C13H15ClO2/c14-12-7-5-10(6-8-12)9-1-3-11(4-2-9)13(15)16/h5-9,11H,1-4H2,(H,15,16)
SMILES:
O=C(C1CCC(C2C=CC(Cl)=CC=2)CC1)O

4-(4-氯苯基)环己基羧酸(95233-37-7)物化性质

实验特性

  • LogP : 3.69840
  • PSA : 37.30000
  • 折射率 : 1.56
  • 沸点 : 387.1±42.0 °C at 760 mmHg
  • 熔点 : 250-255 ºC
  • 闪点 : 187.9±27.9 °C
  • 颜色与性状 : No data available
  • 密度 : 1.2

计算特性

  • 精确分子量 : 238.07600
  • 氢键供体数量 : 1
  • 氢键受体数量 : 2
  • 可旋转化学键数量 : 2
  • 同位素质量 : 238.0760574 g/mol
  • 重原子数量 : 16
  • 复杂度 : 238
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.7
  • 拓扑分子极性表面积 : 37.3
  • 分子量 : 238.71

4-(4-氯苯基)环己基羧酸(95233-37-7)海关数据

海关编码:
2916399090
海关数据:

中国海关编码:

2916399090

概述:

2916399090 其他芳香一元羧酸. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0%

申报要素:

品名, 成分含量, 用途, 丙烯酸、丙烯酸盐或酯应报明包装

Summary:

2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

4-(4-氯苯基)环己基羧酸(95233-37-7)推荐厂家 更多厂家(30)

公司名称手机号/电话联系人QQ微信询单
上海吉至生化科技有限公司 18117592386
021-57481218
吉至试剂 3007522982
询单
湖北方德新材料有限公司 18086096695邱经理 1462312301
询单
赫澎(上海)生物科技有限公司 13122891558
186-16545970
张硕 3418426269
询单
湖北鸿鑫瑞宇精细化工有限公司 17771822910
027-65385071
陈欣 2056564811
询单
JACS-郑州杰克斯化工产品有限公司 15981966935
0371-86259281
杰克斯JACS 893596907
询单
JACS-郑州杰克斯化工产品有限公司 15981966935
0371-86259281
杰克斯JACS 893596907
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
铼博(上海)生化科技有限公司 13311756052
021-60536361 13311756052 13311756131
张经理 2851717387
询单
上海一基实业有限公司 13311756052
021-60526763 13311756052 13311756131
胡经理 2355265332
询单
上海腾准生物科技有限公司 19821570922
021-34053661
张经理 3003871136
询单

4-(4-氯苯基)环己基羧酸(95233-37-7)合成路线

合成路线:1 步
反应条件:
参考文献:
Process for preparation of Atovaquone and polymorph thereof
, India, , ,
合成路线:1 步
反应条件:
参考文献:
Process for the preparation of 4-(4-chlorphenyl)cyclohexanecarboxylic acid
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Synthesis of 4-(4-chlorophenyl)cyclohexanecarboxylic acid
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Process for preparation of 4-(4-chlorophenyl)cyclohexyl-1-formic acid 4-(4-chlorophenyl)-cyclohexyl-1-formic acid
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Medicaments for the treatment of toxoplasmosis
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of spirocycloalkylazetidinones as hypocholesterolemic agents.
, United States, , ,
合成路线:1 步
参考文献:
Pharmaceutical compositions containing cyclohexylnaphtoquinone derivatives for treating Babesia infection
, United States, , ,
合成路线:1 步
参考文献:
Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of Pneumocystis carinii infections
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Combination of atovaquone with proguanil for the treatment of protozoal infections
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Pharmaceutical compositions containing cyclohexylnaphtoquinone derivatives for treatment of protozoal infections
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Methods and pharmaceutical compositions using 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone for treatment of cryptosporidiosis
, Canada, , ,
合成路线:1 步
参考文献:
2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone for the treatment of toxoplasmosis
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Preparation of naphthoquinone derivatives and pharmaceutical compositions containing them for treatment of infection with Pneumocystis carinii
, Japan, , ,
合成路线:1 步
参考文献:
Naphthoquinone derivatives
, European Patent Organization, , ,

4-(4-氯苯基)环己基羧酸(95233-37-7)上下游

4-(4-氯苯基)环己基羧酸(95233-37-7) MSDS

基础信息

Name:4-(4-Chlorophenyl)cyclohexanecarboxylic acid 97% Material Safety Data Sheet
Synonym:
CAS:95233-37-7
Section 1 - Chemical Product ? MSDS Name:4-(4-Chlorophenyl)cyclohexanecarboxylic acid 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS#Chemical NamecontentEINECS#
95233-37-74-(4-Chlorophenyl)cyclohexanecarboxyli97%unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
? EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
? Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
? General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
? General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
? Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
? Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 95233-37-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
?
Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 255 - 257 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H15ClO2
Molecular Weight: 238.71

Section 10 - STABILITY AND REACTIVITY
? Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, carbon dioxide, acrid smoke and fumes.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
? RTECS#:
CAS# 95233-37-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-(4-Chlorophenyl)cyclohexanecarboxylic acid - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION
?

Section 13 - DISPOSAL CONSIDERATIONS
? Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION
?
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION
?
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 95233-37-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 95233-37-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 95233-37-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A